(Z)-Methyl 7-((3R)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopent-1-en-1-yl)hept-5-enoate

Catalog No. :
ACULXF127
CAS No. :
64812-88-0
Molecular Formula :
C18H26O5
Molecular Weight :
322.40

IUPAC Name:methyl (Z)-7-((3R)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopent-1-en-1-yl)hept-5-enoate

(Z)-Methyl 7-((3R)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopent-1-en-1-yl)hept-5-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$565.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-Methyl 7-((3R)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopent-1-en-1-yl)hept-5-enoate
IUPAC Namemethyl (Z)-7-((3R)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopent-1-en-1-yl)hept-5-enoate
MDL No.MFCD23135401
Molecular FormulaC18H26O5
Molecular Weight322.40
SMILESCOC(=O)CCC/C=C\CC1=C[C@H](OC2CCCCO2)CC1=O
InChI KeyVDKRCABVOSBFSK-UKVHHCBFSA-N
Synonym5-Heptenoic acid, 7-[5-oxo-3-[(tetrahydro-2H-pyran-2-yl)oxy]-1-cyclopenten-1-yl]-, Methyl ester, [3R-(Z)]-;(Z)-Methyl 7-((3R)-5-oxo-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopent-1-en-1-yl)hept-5-enoate;5-Heptenoic acid, 7-[5-oxo-3-[(tetrahydro-2H-pyran-2-yl)oxy]-1-cyclopenten-1-yl]-, methyl ester, [3R-(Z)]- (9CI);Methyl (z)-7-((3r)-5-oxo-3-((tetrahydro-2h-pyran-2-yl)oxy)cyclopent-1-en-1-yl)hept-5-enoate
CAS No.64812-88-0

Synthetic Route by SureRoute

1. ACULXF127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACULXF127 route product structure diagram
    ACULXF12764812-88-0
Inquiry

2. ACULXF127 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACULXF127 route product structure diagram
    ACULXF12764812-88-0
Inquiry

Comments (0)